2024: A Year of Growth, Innovation, and Collaboration
2024 has come to a close. We are proud to reflect on the milestones and achievements we’ve reached together with our incredible team, customers, partners, and supporters. Here’s a look back at what we accomplished this year:
👩🔬 Team Expansion
- Welcomed 3 talented new members to our growing team.
🏥 Diagnostic Implementation
- Successfully rolled out our CE-IVD microRNA liver function test in 5+ clinics, advancing molecular diagnostics.
✅ Service Excellence
- Completed over 80 RNA service projects, achieving 100% customer satisfaction.
🛠 Bioinformatics Innovation
- Developed 2 new pipelines: isomiR analysis and tRNA analysis, enhancing our capabilities.
🧬 Expanded Service Offerings
- Added whole-transcriptome sequencing for mRNA, lncRNA, and circRNA in liquid biopsies to our service portfolio.
📚 Scientific Publications
- Co-authored 14 peer-reviewed publications, contributing to cutting-edge research.
📜 Patents
- Filed 1 new patent and secured patent approvals in 10+ territories.
🎤 Thought Leadership
- Participated in over 10 scientific events, presenting 7 talks, 5 posters, and hosting 3 booths.
🌐 Webinars
- Organized 2 webinars to share knowledge and foster connections.
💶 Funding Achievements
- Secured new support through the EUROSTARS program to fuel our innovations.
📈 Social Media Growth
- Welcomed over 550 new followers to our LinkedIn community.
A Thank You to Our Supporters
None of this would have been possible without the dedication of our team, the trust of our customers, the collaboration of our partners, and the support from our funding agencies. We are truly grateful for your contributions and are excited to continue this journey together in 2025.
Here’s to another year of success and breakthroughs in molecular diagnostics and microRNA biomarkers! 🌟
